Skip to content

Based on my review of the GO-CAM model and the relevant documentation, I will now provide a comprehensive review of the GO-CAM model "gomodel:663d668500003182" (TGFB2-mediated signaling pathway in Human).

Review of GO-CAM Model "TGFB2-mediated signaling pathway (Human)"

Model Overview

This model (gomodel:663d668500003182) represents the TGF-beta2 signaling pathway in humans, illustrating how TGF-beta2 ligand interacts with TGF-beta receptors to activate SMAD-dependent transcriptional regulation.

Model Structure and Pathway Flow

The model contains four main activities arranged in a signaling cascade:

  1. TGF-beta2 (UniProtKB:P61812) functions as a cytokine in the extracellular space
  2. TGF-beta receptor type II (UniProtKB:P37173) receives the signal at the plasma membrane
  3. TGF-beta receptor type I (UniProtKB:P36897) is activated by TGF-beta receptor type II at the plasma membrane
  4. SMAD2 (UniProtKB:Q15796) acts as a DNA-binding transcription factor in the nucleus

The causal flow follows the classic TGF-beta signaling pathway: - TGF-beta2 directly positively regulates TGF-beta receptor type II - TGF-beta receptor type II directly positively regulates TGF-beta receptor type I - TGF-beta receptor type I directly positively regulates SMAD2

Evidence and Literature Support

Each activity and association is supported by experimental evidence, primarily direct assays (ECO:0000314) with references to peer-reviewed publications: - TGF-beta2 cytokine activity is supported by computational analysis - TGF-beta receptor activity is supported by multiple publications including PMID:7774578 and PMID:8752209 - SMAD2 transcription factor activity is supported by PMID:17438144

Strengths of the Model

  1. The model correctly captures the core components of the canonical TGF-beta signaling pathway
  2. Each entity is properly localized (extracellular space, plasma membrane, nucleus)
  3. The causal relations use appropriate predicates (RO:0002629 - directly positively regulates)
  4. All activities are part of the TGF-beta receptor signaling pathway (GO:0007179)
  5. Evidence is provided for each assertion with appropriate references

Suggestions for Improvement

  1. Missing SMAD Complex: According to literature, SMAD2 typically functions as part of a complex with SMAD4. The model could be enhanced by including SMAD4 and representing this complex formation.

  2. Transcriptional Target(s): Following GO-CAM guidelines for DNA-binding transcription factors, SMAD2 should have one or more specific transcriptional targets using the "has input" relationship, with appropriate causal relationships (indirectly positively/negatively regulates).

  3. SMAD2 Phosphorylation: The model could explicitly represent the phosphorylation of SMAD2 by TGF-beta receptor type I, as this is a crucial step in the pathway.

  4. Receptor Complex Formation: According to the signaling receptor activity guidelines, the model could better represent the formation of the TGF-beta receptor complex (type I and type II receptors).

  5. Downstream Effectors: The model currently ends with SMAD2 activation. Adding downstream target genes and their biological effects would provide a more complete picture of the pathway.

Consistency with GO-CAM Guidelines

The model generally follows GO-CAM guidelines: - The use of "directly positively regulates" for causal relationships is appropriate - Activities are properly contextualized with cellular locations - Each activity is part of the relevant biological process

However, according to the DNA-binding transcription factor guidelines, the model should include specific transcriptional targets for SMAD2 with "has input" relationships.

Biological Accuracy

The model accurately represents the core TGF-beta signaling mechanism: 1. TGF-beta2 ligand binding to the TGF-beta type II receptor 2. Recruitment and phosphorylation of the TGF-beta type I receptor 3. Activation of SMAD2 as a transcription factor

This is consistent with the established understanding of TGF-beta signaling as documented in the UniProt entries and literature.

Conclusion

This model provides a good representation of the core TGF-beta2 signaling pathway in humans. It correctly captures the main components, their activities, locations, and causal relationships. To improve the model, I recommend:

  1. Including SMAD4 and its interaction with SMAD2
  2. Adding specific transcriptional targets of SMAD2
  3. Explicitly representing the phosphorylation of SMAD2
  4. Expanding the model to include downstream biological effects

Overall, the model is biologically accurate and follows most GO-CAM guidelines, providing a valuable resource for understanding TGF-beta2 signaling.